166 related articles for article (PubMed ID: 23108857)
1. Eliminating tyrosine sequence variants in CHO cell lines producing recombinant monoclonal antibodies.
Feeney L; Carvalhal V; Yu XC; Chan B; Michels DA; Wang YJ; Shen A; Ressl J; Dusel B; Laird MW
Biotechnol Bioeng; 2013 Apr; 110(4):1087-97. PubMed ID: 23108857
[TBL] [Abstract][Full Text] [Related]
2. Molecular polygamy: The promiscuity of l-phenylalanyl-tRNA-synthetase triggers misincorporation of meta- and ortho-tyrosine in monoclonal antibodies expressed by Chinese hamster ovary cells.
Popp O; Larraillet V; Kettenberger H; Gorr IH; Hilger M; Lipsmeier F; Zeck A; Beaucamp N
Biotechnol Bioeng; 2015 Jun; 112(6):1187-99. PubMed ID: 25545851
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of unintended amino acid sequence changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells.
Guo D; Gao A; Michels DA; Feeney L; Eng M; Chan B; Laird MW; Zhang B; Yu XC; Joly J; Snedecor B; Shen A
Biotechnol Bioeng; 2010 Sep; 107(1):163-71. PubMed ID: 20506532
[TBL] [Abstract][Full Text] [Related]
4. Identifying low-level sequence variants via next generation sequencing to aid stable CHO cell line screening.
Zhang S; Bartkowiak L; Nabiswa B; Mishra P; Fann J; Ouellette D; Correia I; Regier D; Liu J
Biotechnol Prog; 2015; 31(4):1077-85. PubMed ID: 26033952
[TBL] [Abstract][Full Text] [Related]
5. Probing of C-terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media.
Luo J; Zhang J; Ren D; Tsai WL; Li F; Amanullah A; Hudson T
Biotechnol Bioeng; 2012 Sep; 109(9):2306-15. PubMed ID: 22473810
[TBL] [Abstract][Full Text] [Related]
6. A general evidence-based sequence variant control limit for recombinant therapeutic protein development.
Zhang A; Chen Z; Li M; Qiu H; Lawrence S; Bak H; Li N
MAbs; 2020; 12(1):1791399. PubMed ID: 32744138
[TBL] [Abstract][Full Text] [Related]
7. Identification of codon-specific serine to asparagine mistranslation in recombinant monoclonal antibodies by high-resolution mass spectrometry.
Yu XC; Borisov OV; Alvarez M; Michels DA; Wang YJ; Ling V
Anal Chem; 2009 Nov; 81(22):9282-90. PubMed ID: 19852494
[TBL] [Abstract][Full Text] [Related]
8. C-terminal modification of monoclonal antibody drugs: amidated species as a general product-related substance.
Tsubaki M; Terashima I; Kamata K; Koga A
Int J Biol Macromol; 2013 Jan; 52():139-47. PubMed ID: 23022270
[TBL] [Abstract][Full Text] [Related]
9. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?
Chusainow J; Yang YS; Yeo JH; Toh PC; Asvadi P; Wong NS; Yap MG
Biotechnol Bioeng; 2009 Mar; 102(4):1182-96. PubMed ID: 18979540
[TBL] [Abstract][Full Text] [Related]
10. High-level protein expression in scalable CHO transient transfection.
Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
[TBL] [Abstract][Full Text] [Related]
11. Control of misincorporation of serine for asparagine during antibody production using CHO cells.
Khetan A; Huang YM; Dolnikova J; Pederson NE; Wen D; Yusuf-Makagiansar H; Chen P; Ryll T
Biotechnol Bioeng; 2010 Sep; 107(1):116-23. PubMed ID: 20506364
[TBL] [Abstract][Full Text] [Related]
12. Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability.
Kang S; Mullen J; Miranda LP; Deshpande R
Biotechnol Bioeng; 2012 Sep; 109(9):2286-94. PubMed ID: 22447498
[TBL] [Abstract][Full Text] [Related]
13. A clone screening method using mRNA levels to determine specific productivity and product quality for monoclonal antibodies.
Lee CJ; Seth G; Tsukuda J; Hamilton RW
Biotechnol Bioeng; 2009 Mar; 102(4):1107-18. PubMed ID: 18985612
[TBL] [Abstract][Full Text] [Related]
14. A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies.
Kim M; O'Callaghan PM; Droms KA; James DC
Biotechnol Bioeng; 2011 Oct; 108(10):2434-46. PubMed ID: 21538334
[TBL] [Abstract][Full Text] [Related]
15. Characterization and identification of alanine to serine sequence variants in an IgG4 monoclonal antibody produced in mammalian cell lines.
Fu J; Bongers J; Tao L; Huang D; Ludwig R; Huang Y; Qian Y; Basch J; Goldstein J; Krishnan R; You L; Li ZJ; Russell RJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():1-8. PubMed ID: 23122394
[TBL] [Abstract][Full Text] [Related]
16. The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells.
Costa AR; Withers J; Rodrigues ME; McLoughlin N; Henriques M; Oliveira R; Rudd PM; Azeredo J
N Biotechnol; 2013 Jun; 30(5):563-72. PubMed ID: 23247406
[TBL] [Abstract][Full Text] [Related]
17. Early prediction of instability of Chinese hamster ovary cell lines expressing recombinant antibodies and antibody-fusion proteins.
Dorai H; Corisdeo S; Ellis D; Kinney C; Chomo M; Hawley-Nelson P; Moore G; Betenbaugh MJ; Ganguly S
Biotechnol Bioeng; 2012 Apr; 109(4):1016-30. PubMed ID: 22068683
[TBL] [Abstract][Full Text] [Related]
18. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody.
Ren D; Zhang J; Pritchett R; Liu H; Kyauk J; Luo J; Amanullah A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2877-84. PubMed ID: 21900054
[TBL] [Abstract][Full Text] [Related]
19. Predicting the expression of recombinant monoclonal antibodies in Chinese hamster ovary cells based on sequence features of the CDR3 domain.
Pybus LP; James DC; Dean G; Slidel T; Hardman C; Smith A; Daramola O; Field R
Biotechnol Prog; 2014; 30(1):188-97. PubMed ID: 24311306
[TBL] [Abstract][Full Text] [Related]
20. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
